Wednesday, July 13, 2016

BRIEF-Sobi says Health Canada validates Orfadin capsule filing

* Health Canada has initiated review of the application for

approval of Orfadin (nitisinone) capsules for the treatment of

hereditary tyrosinaemia type-1 (HT-1)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)